Inovio Pharmaceuticals Stock Today
| INO Stock | USD 10.37 0.35 3.49% |
Performance9 of 100
| Odds Of DistressOver 70
|
Inovio Pharmaceuticals is selling at 10.37 as of the 23rd of April 2024; that is 3.49% increase since the beginning of the trading day. The stock's open price was 10.02. Inovio Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Inovio Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of February 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 12th of February 1998 | Category Healthcare | Classification Health Care |
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus , cancer, and infectious diseases. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania. The company has 25.91 M outstanding shares of which 2.1 M shares are currently shorted by investors with about 3.53 days to cover. More on Inovio Pharmaceuticals
Moving together with Inovio Stock
| 0.86 | OPT | Opthea | PairCorr |
| 0.71 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
Moving against Inovio Stock
| 0.5 | PCRX | Pacira Pharmaceuticals Financial Report 1st of May 2024 | PairCorr |
| 0.43 | PCVX | VaxcyteInc Financial Report 13th of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 8th of May 2024
Inovio Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Inovio Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Inovio Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Joseph Kim | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Inseego Corp | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Aggressive Defence, Cancer Fighters, Medical Equipment, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Inovio Pharmaceuticals report their recommendations after researching Inovio Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Inovio Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Inovio Pharmaceuticals. The Inovio consensus assessment is calculated by taking the average forecast from all of the analysts covering Inovio Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Inovio Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Inovio Pharmaceuticals is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Inovio Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inovio Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Inovio Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inovio Pharmaceuticals' financial leverage. It provides some insight into what part of Inovio Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inovio Pharmaceuticals (INO) is traded on NASDAQ Exchange in USA. It is located in 660 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 and employs 122 people. Inovio Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a total capitalization of 259.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inovio Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Inovio Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Inovio Pharmaceuticals runs under Biotechnology sector within Health Care industry. The entity has 25.91 M outstanding shares of which 2.1 M shares are currently shorted by investors with about 3.53 days to cover.
Inovio Pharmaceuticals has about 348.13 M in cash with (124.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4.
Check Inovio Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationInovio Pharmaceuticals secures a total of 25.91 Million outstanding shares. Roughly 82.0 (percent) of Inovio Pharmaceuticals outstanding shares are held by general public with 1.48 % owned by insiders and only 16.66 pct. by outside corporations. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Inovio Ownership Details
Inovio Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Inovio Pharmaceuticals jumping above the current price in 90 days from now is about 32.27%. The Inovio Pharmaceuticals probability density function shows the probability of Inovio Pharmaceuticals stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 2.3125. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Inovio Pharmaceuticals will likely underperform. Additionally, inovio Pharmaceuticals has an alpha of 0.2502, implying that it can generate a 0.25 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Inovio Pharmaceuticals to move above the current price in 90 days from now is about 32.27 (This Inovio Pharmaceuticals probability density function shows the probability of Inovio Stock to fall within a particular range of prices over 90 days) .
Inovio Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Inovio Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Inovio Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Inovio Pharmaceuticals' value.| Instituion | Recorded On | Shares | |
| Green Alpha Advisors, Llc | 2023-12-31 | 451.7 K | |
| Bank Of America Corp | 2023-09-30 | 414.1 K | |
| Amvescap Plc. | 2023-09-30 | 330.5 K | |
| Morgan Stanley - Brokerage Accounts | 2023-09-30 | 304.2 K | |
| Verition Fund Managegment, Llc | 2023-09-30 | 300 K | |
| Gsa Capital Partners Llp | 2023-09-30 | 296.9 K | |
| Jane Street Group, Llc | 2023-09-30 | 268.6 K | |
| Fmr Inc | 2023-09-30 | 185.3 K | |
| Susquehanna International Group, Llp | 2023-09-30 | 167.7 K | |
| Vanguard Group Inc | 2023-09-30 | 20.1 M | |
| Blackrock Inc | 2023-09-30 | 5.9 M |
Inovio Pharmaceuticals Historical Income Statement
Inovio Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Inovio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Inovio Pharmaceuticals revenue and expense. Inovio Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Inovio Pharmaceuticals' Depreciation And Amortization is very stable compared to the past year. As of the 23rd of April 2024, Total Other Income Expense Net is likely to grow to about 114.8 K, while Interest Expense is likely to drop about 1.2 M. View More FundamentalsInovio Stock Against Markets
Picking the right benchmark for Inovio Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Inovio Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Inovio Pharmaceuticals is critical whether you are bullish or bearish towards Inovio Pharmaceuticals at a given time. Please also check how Inovio Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Inovio Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Inovio Pharmaceuticals Corporate Directors
Inovio Pharmaceuticals corporate directors refer to members of an Inovio Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Inovio Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Inovio Pharmaceuticals' board members must vote for the resolution. The Inovio Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Mort Collins | Independent Director | Profile | |
| Adel Mahmoud | Independent Director | Profile | |
| Wendy Yarno | Director | Profile | |
| Morton Collins | Independent Director | Profile |
How to buy Inovio Stock?
Before investing in Inovio Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Inovio Pharmaceuticals. To buy Inovio Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Inovio Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Inovio Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Inovio Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Inovio Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Inovio Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Inovio Stock please use our How to Invest in Inovio Pharmaceuticals guide.
Already Invested in Inovio Pharmaceuticals?
The danger of trading Inovio Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Inovio Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Inovio Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Inovio Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Inovio Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inovio Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inovio Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inovio Pharmaceuticals Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inovio Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Inovio Stock, please use our How to Invest in Inovio Pharmaceuticals guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Inovio Stock analysis
When running Inovio Pharmaceuticals' price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.09) | Revenue Per Share 0.038 | Quarterly Revenue Growth (0.18) | Return On Assets (0.32) | Return On Equity (0.80) |
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Inovio Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.